Pemvidutide (ALT-801), a novel GLP-1/glucagon dual receptor agonist, achieves rapid and potent reductions in body weight and liver fat: results of a placebo-controlled, double-blind, first-in-human (FIH) clinical trial

Autor:	Stephen Harrison, John Nestor, Sarah Browne, Jacques Payne, Staci Steele, Robert Casper, Anvar Suyundikov, Vyjayanthi Krishnan, Scot Roberts, Joyce James, M.Scot Harris
Rok vydání:	2022
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 77:S88-S89
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(22)00570-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e577e1730052d92749d2aa9a14aab1a6 https://doi.org/10.1016/s0168-8278(22)00570-0 Zobrazit plný text záznamu Full Text from ScienceDirect